Molecular staging of prostate cancer. III. Effects of cystoscopy and needle biopsy on the enhanced reverse transcriptase polymerase chain reaction assay

Journal of Urology

Volumn 157, Issue 5, 1997, Pages 1748-1751

  Cama, Cristoforo ^a   Olsson, Carl A ^a   Buttyan, Ralph ^a   De Vries, Glen M ^a   Wise, Gilbert J ^a   Katz, Aaron E ^a  

^a NONE

Author keywords

polymerase chain reaction; prostate specific antigen; prostatic hypertrophy; prostatic neoplasms; reverse transcriptase

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER STAGING; CARCINOMA IN SITU; CONTROLLED STUDY; CYSTOSCOPY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0030976025     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64851-1     Document Type: Article

References (30)

1. Katz, A. E., Seaman, E., Colombel, R. and Buttyan, R.: Early detection of prostate cancer; a molecular overview. In: Early Detection of Cancer: Molecular Markers. Edited by S. Srivastava. New York: Futura Publishing Co., Inc., chapt. 19, p. 191, 1994.
2. Katz, A. E., Olsson, C. A., Raffo, A., Cama, C., Perlman, H., Seaman, E., O'Toole, K. M., McMahon, D., Benson, M. C. and Buttyan, R.: Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology, 43: 765, 1994.
3. Wang, M. C., Valenzuela, L. A., Murphy, G. P. and Chu, T. M.: Purification of a human prostate specific antigen. Invest. Urol., 17: 159, 1979.
4. Lilja, H.: A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J. Clin. Invest., 76: 1899, 1985.
5. Belanger, A., van Halbeek, H., Graves, H. C., Grandbois, K., Stamey, T. A., Huang, L., Poppe, I. and Labrie, F.: Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard. Prostate, 27: 187, 1995.
6. Stamey, T. A., Kabalin, J. N., McNeal, J. E., Johnstone, I. M., Freiha, F., Redwine, E. A. and Yang, N.: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J. Urol., 141: 1076, 1989.
7. Partin, A. W., Carter, H. B., Chan, D. W., Epstein, J. I., Oesterling, J. E., Rock, R. C., Weber, J. P. and Walsh, P. C.: Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J. Urol., 143: 747, 1990.
8. Yuan, J. J. J., Coplen, D. E., Petros, J. A., Figenshau, R. S., Ratliff, T. L., Smith, D. S. and Catalona, W. J.: Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels. J. Urol., 147: 810, 1992.
9. Chybowski, F. M., Bergstralh, E. J. and Oesterling, J. E.: The effect of digital rectal examination on the serum prostate specific antigen concentration: results of a randomized study. J. Urol., 148: 83, 1992.
10. Stamey, T. A.: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. Monogr. Urol., 10: 50, 1989.
11. Horoszewicz, J. S., Leung, S. S., Kawinski, E., Karr, J. P., Rosenthal, H., Chu, T. M., Mirand, E. A. and Murphy, G. P.: LNCaP model of human prostatic carcinoma. Cancer Res., 43: 1809, 1983.
12. Klobeck, H. G., Combriato, G., Schultz, P., Arbusow, V. and Fittler, F.: Genomic sequences of human prostate specific antigen (PSA). Nucl. Acids Res., 17: 3981, 1989.
13. Rosen, M. A., Goldstone, L., Lapin, S., Wheeler, T. and Scardino, P. T.: Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens. J. Urol., 148: 331, 1992.
14. Lange, P. H. and Narayan, P.: Understaging and undergrading of prostate cancer: argument for postoperative radiation as adjuvant therapy. Urology, 21: 113, 1983.
15. Bigg, S. W., Kavoussi, L. R. and Catalona, W. J.: Role of nerve-sparing radical prostatectomy for clinical stage B2 prostate cancer. J. Urol., 144: 1420, 1990.
16. Anscher, M. S. and Prosnitz, L. R.: Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule. J. Urol., 138: 1407, 1987.
17. Jones, E. C.: Resection margin status in radical retropubic prostatectomy specimens: relationship to type of operation, tumor size, tumor grade and local tumor extension. J. Urol., 144: 89, 1990.
18. Bosch, R. J. L. H., Kurth, K. H. and Schroeder, F. H.: Surgical treatment of locally advanced (T3) prostatic carcinoma: early results. J. Urol., 138: 816, 1987.
19. Trapasso, J. G., deKernion, J. B., Smith, R. B. and Dorey, F.: The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. J. Urol., 152: 1821, 1994.
20. Schellhammer, P. F.: Radical prostatectomy. Patterns of local failure and survival in 67 patients. Urology, 31: 191, 1988.
21. Lange, P. H., Ercole, C. J. and Vessella, R. L.: Serum prostatic specific antigen (PSA) in the management of patients after radical prostatectomy (RP). J. Urol., part 2, 139: 314A, abstract 607, 1988.
22. Frazier, H. A., Robertson, J. E., Humphrey, P. A. and Paulson, D. F.: Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy. J. Urol., 149: 516, 1993.
23. Moreno, J. G., Croce, C. M., Fischer, R., Monne, M., Vihko, P., Mulholland, S. G. and Gomella, L. G.: Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res., 52: 6110, 1992.
24. Israeli, R. S., Miller, W. H., Jr., Su, S. L., Powell, C. T., Fair, W. R., Samadi, D. S., Huryk, R. F., DeBlasio, A., Edwards, E. T. and Wise, G. J.: Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res., 54: 6306, 1994.
25. Seiden, M. V., Kantoff, P. W., Krithivas, K., Propert, K., Bryant, M., Haltom, E., Gaynes, L., Kaplan, I., Bubley, G. and DeWolf, W.: Detection of circulating tumor cells in men with localized prostate cancer. J. Clin. Oncol., 12: 2634, 1994.
26. Deguchi, T., Doi, T., Ehara, H., Ito, S., Takahashi, Y., Nishino, Y., Fujihiro, S., Kawamura, T., Komeda, H. and Horie, M.: Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res., 53: 5350, 1993.
27. Wood, D. P., Jr., Banks, E. R., Humphreys, S., McRoberts, J. W. and Rangnekar, V. M.: Identification of bone marrow micrometastases in patients with prostate cancer. Cancer, 74: 2533, 1994.
28. Cama, C., Olsson, C. A., Raffo, A. J., Perlman, H., Buttyan, R., O'Toole, K., McMahon, D., Benson, M. C. and Katz, A. E.: Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen. J. Urol., 153: 1373, 1995.
29. Katz, A. E., de Vries, G. M., Begg, M. D., Raffo, A. J., Cama, C., O'Toole, K., Buttyan, R., Benson, M. C. and Olsson, C. A.: Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer, 75: 1642, 1995.
30. Oefelein, M. G., Kaul, K., Herz, B., Blum, M. D., Holland, J. M., Keeler, T. C., Cook, W. A. and Ignatoff, J. M.: Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy. J. Urol., 155: 238, 1996.